资源 search news articles 所有项目 2024 (1) 2023 (15) 2022 (16) 2021 (7) 2020 (1) 03月 25日, 2024 Dr. Bradford Navia, Chief Medical Officer, presented “APN 1607: A Promising PET Tracer for Tauopathies of All Isoform Types” at the Tau 2024 Global Conference, March 25-26, 2024. 12月 22日, 2023 Investigating neural dysfunction with abnormal protein deposition in Alzheimer’s disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography 10月 30日, 2023 Protein Degradation in CNS: A new era of disease modifying therapies. Dr. Paul Tempest, former Head of Medicinal Chemistry, presented at 6th Annual TPD Boston 2023 10月 23日, 2023 18F-APN-1607: A Promising PET Tracer for Tauopathies of All Isoform Repeat Types. Dr. Bradford Navia, Chief Medical Officer, presents at ADDF Therapeutics Day, Boston 10月 14日, 2023 Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithm 09月 21日, 2023 Nonfluent Variant Primary Progressive Aphasia on FDG, 11C-PIB, and 18F-APN-1607 PET Imaging 07月 20日, 2023 Improved interpretation of 18F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier 06月 29日, 2023 Head‑to‑head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints 06月 01日, 2023 Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration 05月 12日, 2023 Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease 页 1 之 4 早期发布 有兴趣加入我们吗？
